{"id":"W2026961444","doi":"10.1038/sj.cgt.7700626","title":"A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer","year":2003,"lang":"en","type":"article","venue":"Cancer Gene Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"Princess Margaret Hospital Foundation","keywords":"Medicine; Prostate cancer; Prostatectomy; Immunotherapy; Prostate-specific antigen; CD8; Prostate; Urology; Internal medicine; Cytokine; Urinary system; Tumor necrosis factor alpha; Toxicity; Cancer; Antigen; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008472153,0.001747797,0.001702628,0.0005643777,0.0004852888,0.001188603,0.0009916084,0.001705346,0.00244537],"category_scores_gemma":[0.0004537425,0.000513108,0.001159003,0.000466512,0.001587158,0.000827069,0.0003046351,0.003841,0.0005391332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009592743,"about_ca_system_score_gemma":0.001343177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001761539,"about_ca_topic_score_gemma":0.003177127,"domain_scores_codex":[0.9996747,0.00009476063,0.000009862594,0.00006851849,0.00003017896,0.0001220465],"domain_scores_gemma":[0.9996898,0.00005794395,0.00004819361,0.00004117464,0.00001318925,0.0001497426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5465763,0.1327032,0.003034087,0.001095023,0.00127262,0.0005185567,0.0005039608,0.007386421,0.2055932,0.001749045,0.004933598,0.09463388],"study_design_scores_gemma":[0.4043486,0.5642393,0.0038825,0.00003634174,0.0004212506,0.0002833514,0.0001072166,0.001804447,0.02164102,0.0004308841,0.002766884,0.00003828468],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909958,0.002335935,0.000901502,0.0007132827,0.0004031885,0.0016163,0.0006331609,0.0001563382,0.002244476],"genre_scores_gemma":[0.9909863,0.001618819,0.001327561,0.0005746356,0.0001548445,0.001606133,0.0009556669,0.00003185922,0.002744209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00244537,"threshold_uncertainty_score":0.008180559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01605563853150486,"score_gpt":0.2828238687916225,"score_spread":0.2667682302601176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}